Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells

133Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims: Here we aimed to firstly investigate the role of miR-27a in proliferation and multidrug resistance of gastric cancer cells. Methods: The role of miR-27a in gastric cancer cells was detected using MTT assay, soft agar assay, flow cytometry assay, nude mice assay, real-time PCR, western blot and reporter gene assay, etc. Results: Down-regulation of miR-27a could inhibit porliferation of gastric cancer cells in vitro and in vivo. Down-regulation of miR-27a could also confer sensitivity of drugs on gastric cancer cells, and might increase accumulation and decrease releasing amount of adriamycin in gastric cancer cells. Down-regulation of miR-27a could significantly decrease the expression of P-glycoprotein and the transcriptional activity of cyclin D1, and up-regulate the expression of p21. Conclusions: MiR-27a might play important roles in porliferation and drug resistance of gastric cancer. MiR-27a might be considered as a useful target for cancer therapy. © 2011 Zhao et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Zhao, X., Yang, L., & Hu, J. (2011). Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. Journal of Experimental and Clinical Cancer Research, 30(1). https://doi.org/10.1186/1756-9966-30-55

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free